


MVK Pharmaceuticals
Pharmaceutical Manufacturing • Indianapolis, Indiana, United States • 1-10 Employees
Company overview
| Headquarters | 5th Floor, Suite E504, 1800 North Capitol Avenue, Indianapolis, IN 46202, US |
| Phone number | +13173742178 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 2017 |
| Employees | 1-10 |
| Socials |
Key Contact at MVK Pharmaceuticals
Neal Naito
Chief Executive Officer
About MVK Pharmaceuticals
Revolutionizing CNS Treatments through Nanomedicine MVK Pharmaceuticals is an early-stage drug development company that has completed positive preclinical trials and is in the process of submitting an IND package to the FDA to begin Phase I human studies. The company seeks to advance a first-in-class treatment of suicidal ideation with major depression through intranasal delivery of a three amino acid neuropeptide loaded in a biodegradable nanoparticle. Success will launch a pipeline of drugs for various treatments that range from PTSD, TBI, anxiety, sleep, addictions, epilepsy, and other disorders.
MVK Pharmaceuticals revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
MVK Pharmaceuticals has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
MVK Pharmaceuticals has never raised funding before.
MVK Pharmaceuticals Tech Stack
Discover the technologies and tools that power MVK Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Performance
Frequently asked questions
4.8
40,000 users



